Pentwater Capital Management LP Global Blood Therapeutics, Inc. Transaction History

Pentwater Capital Management LP

  • $9.58 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$32.4 - $68.18 $104 Million - $218 Million
3,200,000 New
3,200,000 $218 Million
Q3 2019

Nov 14, 2019
SELL
$45.35 - $57.91 $517,897 - $661,332
-11,420 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$52.6 - $63.29 $600,692 - $722,771
11,420 New
11,420 $601,000

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Pentwater Capital Management LP Portfolio

Follow Pentwater Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Pentwater Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email